Chinese General Practice ›› 2023, Vol. 26 ›› Issue (08): 927-932.DOI: 10.12114/j.issn.1007-9572.2022.0611
• Original Research • Previous Articles Next Articles
Received:
2022-04-25
Revised:
2022-09-10
Published:
2023-03-15
Online:
2022-10-09
Contact:
LIAO Xin
通讯作者:
廖鑫
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0611
组别 | 例数 | 年龄(岁) | 身高(m) | 体质量(kg) | BMI(kg/m2) | 腰围(cm) | 臀围(cm) | WHR | FPG(mmol/L) |
---|---|---|---|---|---|---|---|---|---|
对照组 | 45 | 26.2±3.7 | 1.57±0.06 | 53.19±7.41 | 21.7±3.1 | 74.26±4.27 | 93.97±3.55 | 0.79±0.06 | 4.41±0.67 |
非HA组 | 51 | 24.2±5.4 | 1.58±0.06 | 61.23±7.53a | 27.4±3.6a | 80.49±9.47a | 96.72±5.98a | 0.83±0.06a | 4.84±0.73a |
HA组 | 65 | 24.5±4.7 | 1.57±0.08 | 66.65±13.07a | 25.6±4.0a | 85.00±13.13a | 98.49±7.42a | 0.86±0.12a | 5.12±1.18a |
F值 | 1.937 | 0.433 | 15.149 | 16.353 | 9.006 | 3.600 | 5.110 | 4.758 | |
P值 | 0.150 | 0.650 | <0.001 | <0.05 | <0.05 | <0.05 | <0.05 | <0.05 | |
组别 | FINS(μU/ml) | HOMA-IR | HbA1c(%) | TG(mmol/L) | TC(mmol/L) | LDL(mmol/L) | HDL(mmol/L) | FSH(mU/ml) | |
对照组 | 7.32±2.30 | 1.45±0.56 | 4.93±0.37 | 1.14±0.24 | 4.42±0.73 | 2.55±0.36 | 1.47±0.19 | 5.01±1.56 | |
非HA组 | 17.58±8.52a | 3.77±1.89a | 5.31±0.55a | 1.36±0.66a | 4.35±0.79 | 3.00±0.92a | 1.26±0.32a | 5.96±1.63a | |
HA组 | 23.24±14.03a | 5.19±3.24ab | 5.47±0.46a | 1.76±0.73ab | 4.61±0.88 | 2.92±0.89a | 1.08±0.19ab | 5.87±1.67ab | |
F值 | 20.500 | 244.883 | 9.963 | 8.321 | 1.852 | 2.673 | 20.68 | 3.386 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | 0.163 | 0.074 | <0.001 | 0.038 | |
组别 | LH(mU/ml) | 孕酮(nmol/L) | TEST(nmol/L) | SHBG(nmol/L) | DHEA-S(umol/L) | FAI | ADPN(mg/dl) | ||
对照组 | 7.2±2.47 | 2.37±1.10 | 1.02±0.40 | 40.34±8.70 | 207.3±25.26 | 2.94±2.84 | 178.03±13.43 | ||
非HA组 | 8.27±5.26 | 1.64±1.91 | 1.35±0.35a | 53.32±37.67 | 215.94±81.34 | 3.45±2.00a | 174.96±18.15 | ||
HA组 | 8.51±4.83 | 1.24±1.34ab | 3.04±0.53ab | 33.67±17.33ab | 227.31±113.60 | 11.28±5.63ab | 126.18±26.21ab | ||
F值 | 0.778 | 3.139 | 50.123 | 59.147 | 56.56 | 313.237 | 91.675 | ||
P值 | 0.462 | <0.05 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 1 Comparison of general information and clinical biochemical indexes among three groups
组别 | 例数 | 年龄(岁) | 身高(m) | 体质量(kg) | BMI(kg/m2) | 腰围(cm) | 臀围(cm) | WHR | FPG(mmol/L) |
---|---|---|---|---|---|---|---|---|---|
对照组 | 45 | 26.2±3.7 | 1.57±0.06 | 53.19±7.41 | 21.7±3.1 | 74.26±4.27 | 93.97±3.55 | 0.79±0.06 | 4.41±0.67 |
非HA组 | 51 | 24.2±5.4 | 1.58±0.06 | 61.23±7.53a | 27.4±3.6a | 80.49±9.47a | 96.72±5.98a | 0.83±0.06a | 4.84±0.73a |
HA组 | 65 | 24.5±4.7 | 1.57±0.08 | 66.65±13.07a | 25.6±4.0a | 85.00±13.13a | 98.49±7.42a | 0.86±0.12a | 5.12±1.18a |
F值 | 1.937 | 0.433 | 15.149 | 16.353 | 9.006 | 3.600 | 5.110 | 4.758 | |
P值 | 0.150 | 0.650 | <0.001 | <0.05 | <0.05 | <0.05 | <0.05 | <0.05 | |
组别 | FINS(μU/ml) | HOMA-IR | HbA1c(%) | TG(mmol/L) | TC(mmol/L) | LDL(mmol/L) | HDL(mmol/L) | FSH(mU/ml) | |
对照组 | 7.32±2.30 | 1.45±0.56 | 4.93±0.37 | 1.14±0.24 | 4.42±0.73 | 2.55±0.36 | 1.47±0.19 | 5.01±1.56 | |
非HA组 | 17.58±8.52a | 3.77±1.89a | 5.31±0.55a | 1.36±0.66a | 4.35±0.79 | 3.00±0.92a | 1.26±0.32a | 5.96±1.63a | |
HA组 | 23.24±14.03a | 5.19±3.24ab | 5.47±0.46a | 1.76±0.73ab | 4.61±0.88 | 2.92±0.89a | 1.08±0.19ab | 5.87±1.67ab | |
F值 | 20.500 | 244.883 | 9.963 | 8.321 | 1.852 | 2.673 | 20.68 | 3.386 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | 0.163 | 0.074 | <0.001 | 0.038 | |
组别 | LH(mU/ml) | 孕酮(nmol/L) | TEST(nmol/L) | SHBG(nmol/L) | DHEA-S(umol/L) | FAI | ADPN(mg/dl) | ||
对照组 | 7.2±2.47 | 2.37±1.10 | 1.02±0.40 | 40.34±8.70 | 207.3±25.26 | 2.94±2.84 | 178.03±13.43 | ||
非HA组 | 8.27±5.26 | 1.64±1.91 | 1.35±0.35a | 53.32±37.67 | 215.94±81.34 | 3.45±2.00a | 174.96±18.15 | ||
HA组 | 8.51±4.83 | 1.24±1.34ab | 3.04±0.53ab | 33.67±17.33ab | 227.31±113.60 | 11.28±5.63ab | 126.18±26.21ab | ||
F值 | 0.778 | 3.139 | 50.123 | 59.147 | 56.56 | 313.237 | 91.675 | ||
P值 | 0.462 | <0.05 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | ADPN |
---|---|---|
Q1亚组 | 12 | 158.32±15.92 |
Q2亚组 | 15 | 146.18±11.29a |
Q3亚组 | 21 | 136.08±12.98ab |
Q4亚组 | 17 | 121.54±13.36abc |
F值 | 15.536 | |
P值 | <0.001 |
Table 2 Comparison of ADPN in different TEST levels subgroups in HA group
组别 | 例数 | ADPN |
---|---|---|
Q1亚组 | 12 | 158.32±15.92 |
Q2亚组 | 15 | 146.18±11.29a |
Q3亚组 | 21 | 136.08±12.98ab |
Q4亚组 | 17 | 121.54±13.36abc |
F值 | 15.536 | |
P值 | <0.001 |
组别 | 例数 | ADPN |
---|---|---|
Q1'亚组 | 10 | 181.77±11.10 |
Q2'亚组 | 11 | 172.40±10.13a |
Q3'亚组 | 18 | 160.25±6.53ab |
Q4'亚组 | 12 | 145.16±4.26abc |
F值 | 30.409 | |
P值 | <0.05 |
Table 3 Comparison of ADPN in different TEST levels subgroups in non-HA group
组别 | 例数 | ADPN |
---|---|---|
Q1'亚组 | 10 | 181.77±11.10 |
Q2'亚组 | 11 | 172.40±10.13a |
Q3'亚组 | 18 | 160.25±6.53ab |
Q4'亚组 | 12 | 145.16±4.26abc |
F值 | 30.409 | |
P值 | <0.05 |
组别 | 例数 | 年龄(岁) | 身高(m) | 体质量(kg) | BMI(kg/m2) | 腰围(cm) | 臀围(cm) | WHR〔M(P25,P75)〕 |
---|---|---|---|---|---|---|---|---|
PCOS+NW亚组 | 47 | 24.0±4.4 | 1.58±0.06 | 59.49±7.95 | 22.3±2.1 | 78.24±8.91 | 95.41±5.52 | 0.81(0.81,0.90) |
非PCOS+NW亚组 | 21 | 26.2±2.8 | 1.58±0.05 | 50.53±5.27a | 20.2±1.7a | 74.83±4.30 | 94.92±3.13 | 0.78(0.77,0.85) |
PCOS+OW亚组 | 69 | 24.6±5.3 | 1.57±0.07 | 65.94±11.57 | 28.4±2.9 | 84.77±12.16 | 98.59±7.06 | 0.85(0.81,0.90) |
非PCOS+OW亚组 | 24 | 26.1±5.6 | 1.53±0.06 | 60.19±7.92 | 25.8±2.0b | 72.76±4.08b | 91.50±3.57b | 0.80(0.73,0.86) |
F(H)值 | 1.170 | 1.651 | 13.994 | 78.075 | 8.239 | 5.277 | 19.259c | |
P值 | 0.324 | 0.181 | <0.001 | <0.001 | <0.001 | <0.001 | <0.05 | |
组别 | FPG〔M(P25,P75),mmol/L〕 | FINS(μU/ml) | HOMA-IR〔M(P25,P75)〕 | HbA1c(%) | TG(mmol/L) | TC(mmol/L) | LDL(mmol/L) | HDL(mmol/L) |
PCOS+NW亚组 | 5.14(4.60,5.50) | 20.00±9.42 | 3.82(3.20,5.50) | 5.34±0.47 | 1.58±0.74 | 4.61±0.98 | 3.20±0.90 | 1.19±0.25 |
非PCOS+NW亚组 | 4.63(3.97,5.05) | 6.90±2.06a | 1.41(0.90,1.90)a | 4.98±0.42a | 1.13±0.21a | 4.51±0.75 | 2.54±0.39a | 1.48±0.19a |
PCOS+OW亚组 | 4.76(4.25,5.50) | 20.60±12.91 | 3.82(2.40,5.90) | 5.41±0.53 | 1.55±0.72 | 4.42±0.77 | 2.86±0.89 | 1.16±0.29 |
非PCOS+OW亚组 | 4.26(3.40,4.83) | 8.42±2.68b | 1.45(1.10,1.80)b | 4.81±0.13b | 1.19±0.32 | 4.19±0.67 | 2.57±0.28 | 1.45±0.21b |
F(H)值 | 11.851c | 11.426 | 55.340c | 7.017 | 3.079 | 0.717 | 3.244 | 10.348 |
P值 | <0.05 | <0.001 | <0.001 | <0.001 | <0.05 | 0.544 | <0.05 | <0.001 |
组别 | FSH(mU/ml) | LH(mU/ml) | 孕酮〔M(P25,P75),nmol/L〕 | TEST(nmol/L) | SHBG(nmol/L) | FAI | DHEA-S(μmol/L) | ADPN(mg/dl) |
PCOS+NW亚组 | 6.09±1.99 | 8.82±4.91 | 1.04(0.49,1.77) | 2.03±0.94 | 36.03±16.79 | 6.38±4.78 | 219.55±98.76 | 162.7±25.41 |
非PCOS+NW亚组 | 4.96±1.51a | 7.06±2.38 | 2.60(1.60,3.15)a | 1.05±0.46a | 39.66±9.67 | 3.20±3.30a | 211.15±26.24 | 181.37±13.63a |
PCOS+OW亚组 | 5.83±1.48 | 8.20±5.10 | 0.90(0.62,1.72) | 2.57±0.89 | 40.96±19.99 | 9.56±7.10 | 222.56±99.04 | 145.12±3.50 |
非PCOS+OW亚组 | 5.13±1.79 | 7.56±2.83 | 2.50(1.63,2.95)b | 0.93±0.18b | 42.11±5.51 | 2.27±0.65b | 197.20±20.60 | 172.27±8.19b |
F(H)值 | 2.488 | 0.650 | 22.364c | 17.662 | 0.589 | 8.376 | 0.253 | 9.518 |
P值 | 0.064 | 0.580 | <0.001 | <0.001 | 0.624 | <0.001 | 0.859 | <0.001 |
Table 4 Comparison of general conditions and clinical biochemical indicators after grouping all subjects according to BMI
组别 | 例数 | 年龄(岁) | 身高(m) | 体质量(kg) | BMI(kg/m2) | 腰围(cm) | 臀围(cm) | WHR〔M(P25,P75)〕 |
---|---|---|---|---|---|---|---|---|
PCOS+NW亚组 | 47 | 24.0±4.4 | 1.58±0.06 | 59.49±7.95 | 22.3±2.1 | 78.24±8.91 | 95.41±5.52 | 0.81(0.81,0.90) |
非PCOS+NW亚组 | 21 | 26.2±2.8 | 1.58±0.05 | 50.53±5.27a | 20.2±1.7a | 74.83±4.30 | 94.92±3.13 | 0.78(0.77,0.85) |
PCOS+OW亚组 | 69 | 24.6±5.3 | 1.57±0.07 | 65.94±11.57 | 28.4±2.9 | 84.77±12.16 | 98.59±7.06 | 0.85(0.81,0.90) |
非PCOS+OW亚组 | 24 | 26.1±5.6 | 1.53±0.06 | 60.19±7.92 | 25.8±2.0b | 72.76±4.08b | 91.50±3.57b | 0.80(0.73,0.86) |
F(H)值 | 1.170 | 1.651 | 13.994 | 78.075 | 8.239 | 5.277 | 19.259c | |
P值 | 0.324 | 0.181 | <0.001 | <0.001 | <0.001 | <0.001 | <0.05 | |
组别 | FPG〔M(P25,P75),mmol/L〕 | FINS(μU/ml) | HOMA-IR〔M(P25,P75)〕 | HbA1c(%) | TG(mmol/L) | TC(mmol/L) | LDL(mmol/L) | HDL(mmol/L) |
PCOS+NW亚组 | 5.14(4.60,5.50) | 20.00±9.42 | 3.82(3.20,5.50) | 5.34±0.47 | 1.58±0.74 | 4.61±0.98 | 3.20±0.90 | 1.19±0.25 |
非PCOS+NW亚组 | 4.63(3.97,5.05) | 6.90±2.06a | 1.41(0.90,1.90)a | 4.98±0.42a | 1.13±0.21a | 4.51±0.75 | 2.54±0.39a | 1.48±0.19a |
PCOS+OW亚组 | 4.76(4.25,5.50) | 20.60±12.91 | 3.82(2.40,5.90) | 5.41±0.53 | 1.55±0.72 | 4.42±0.77 | 2.86±0.89 | 1.16±0.29 |
非PCOS+OW亚组 | 4.26(3.40,4.83) | 8.42±2.68b | 1.45(1.10,1.80)b | 4.81±0.13b | 1.19±0.32 | 4.19±0.67 | 2.57±0.28 | 1.45±0.21b |
F(H)值 | 11.851c | 11.426 | 55.340c | 7.017 | 3.079 | 0.717 | 3.244 | 10.348 |
P值 | <0.05 | <0.001 | <0.001 | <0.001 | <0.05 | 0.544 | <0.05 | <0.001 |
组别 | FSH(mU/ml) | LH(mU/ml) | 孕酮〔M(P25,P75),nmol/L〕 | TEST(nmol/L) | SHBG(nmol/L) | FAI | DHEA-S(μmol/L) | ADPN(mg/dl) |
PCOS+NW亚组 | 6.09±1.99 | 8.82±4.91 | 1.04(0.49,1.77) | 2.03±0.94 | 36.03±16.79 | 6.38±4.78 | 219.55±98.76 | 162.7±25.41 |
非PCOS+NW亚组 | 4.96±1.51a | 7.06±2.38 | 2.60(1.60,3.15)a | 1.05±0.46a | 39.66±9.67 | 3.20±3.30a | 211.15±26.24 | 181.37±13.63a |
PCOS+OW亚组 | 5.83±1.48 | 8.20±5.10 | 0.90(0.62,1.72) | 2.57±0.89 | 40.96±19.99 | 9.56±7.10 | 222.56±99.04 | 145.12±3.50 |
非PCOS+OW亚组 | 5.13±1.79 | 7.56±2.83 | 2.50(1.63,2.95)b | 0.93±0.18b | 42.11±5.51 | 2.27±0.65b | 197.20±20.60 | 172.27±8.19b |
F(H)值 | 2.488 | 0.650 | 22.364c | 17.662 | 0.589 | 8.376 | 0.253 | 9.518 |
P值 | 0.064 | 0.580 | <0.001 | <0.001 | 0.624 | <0.001 | 0.859 | <0.001 |
因变量 | 自变量 | B | 95%CI | SE | β | t值 | P值 |
---|---|---|---|---|---|---|---|
FAI | ADPN | -0.066 | (-0.098,-0.034) | 0.015 | -0.877 | -4.300 | <0.001 |
BMI | -0.135 | (-0.248,-0.022) | 0.053 | -0.456 | -2.525 | 0.022 | |
ADPN | HOMA-IR | -6.744 | (-12.269,-1.220) | 2.618 | -0.354 | -2.576 | 0.020 |
FAI | -7.921 | (-11.808,-4.035) | 1.842 | -0.594 | -4.300 | <0.001 | |
BMI | -1.748 | (-2.892,-0.605) | 0.542 | -0.443 | -3.225 | 0.05 |
Table 5 Multiple linear regression analysis of influencing factors of FAI and ADPN in the non-HA group
因变量 | 自变量 | B | 95%CI | SE | β | t值 | P值 |
---|---|---|---|---|---|---|---|
FAI | ADPN | -0.066 | (-0.098,-0.034) | 0.015 | -0.877 | -4.300 | <0.001 |
BMI | -0.135 | (-0.248,-0.022) | 0.053 | -0.456 | -2.525 | 0.022 | |
ADPN | HOMA-IR | -6.744 | (-12.269,-1.220) | 2.618 | -0.354 | -2.576 | 0.020 |
FAI | -7.921 | (-11.808,-4.035) | 1.842 | -0.594 | -4.300 | <0.001 | |
BMI | -1.748 | (-2.892,-0.605) | 0.542 | -0.443 | -3.225 | 0.05 |
因变量 | 自变量 | B | 95%CI | SE | β | t值 | P值 |
---|---|---|---|---|---|---|---|
FAI | ADPN | -0.123 | (-0.213,-0.032) | 0.045 | -0.441 | -2.747 | 0.009 |
ADPN | FAI | -1.266 | (-2.198,-0.335) | 0.461 | -0.378 | -2.747 | 0.009 |
HOMA-IR | -2.663 | (-5.092,-0.335) | 1.202 | -0.347 | -2.215 | 0.032 |
Table 6 Multiple linear regression analysis of influencing factors of FAI and ADPN in the HA group
因变量 | 自变量 | B | 95%CI | SE | β | t值 | P值 |
---|---|---|---|---|---|---|---|
FAI | ADPN | -0.123 | (-0.213,-0.032) | 0.045 | -0.441 | -2.747 | 0.009 |
ADPN | FAI | -1.266 | (-2.198,-0.335) | 0.461 | -0.378 | -2.747 | 0.009 |
HOMA-IR | -2.663 | (-5.092,-0.335) | 1.202 | -0.347 | -2.215 | 0.032 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J]. Fertil Steril,2004,81(1):19-25. DOI:10.1016/j.fertnstert.2003.10.004.
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||